= LhARA Steering Group meeting !#4 = //**24^th^ September 2020 10:00 GMT**// == Notes == 1. **[wiki:Research/DesignStudy/SteeringGroup/2020-07-03 Notes of last meeting and actions arising:]** * **KL**: Set up series of meetings with leads at partner organisations to discuss preparation of R&D programme. - **Superceded.** * **KL/CB**: Consider meeting between Imperial (and other) ion-accelerator experts with the relevant experts in CLF. - **Ongoing.** * **KL/KK**: to collaborate on the development for a proposal for such a meeting on the timescale of November 2020. - **Ongoing.** * **KL**: Ensure one representative per group at the next LhARA SG meeting. - **Stands.** * **KL**: Raise NIHR engagement with K.Gleeson. - **Done.** * **KL**: Seek PPI representative for SG. - **Done.** Welcome G. Jones and H. Hall. * **KK, JPar, CW, KL**: Make relevant contact with local PPI groups as described in item 4. - StG: Brm is not a radiotherapy research centre. Shoudl contact Manchester, Oxford, and Liverpool. - TG: Also need to contact with relevant medical physics groups. * **KL&JPar**: Write to CTRAD w/s 4 chair (KK) to ask how we might work together to raise awarenents of our programme among the patient and clinician communitites. - **Done.** Letter written and sent, see under clinician engagement below. Revised action needs to be agreed. * **KK, JPar, CW, KL, SG**: Make relevant contact with local clinician groups as described in item 4. - **Ongoing.** * **KL**: Write to J.Clarke to ask for support to reach out to relevant industry. - **Stands.** * **PA**: Make contact with MTC to see how to make contact with relevant industry. - Stands * **PA/KL** will cooperate in drafting a letter. - **Stands.** * **KL**: Review proposed w/p structure and skills matrix taking into account comments under item 4. - **Stands. * **KL/RMcL**: Liaise to generate small group to coordinate development of instrumentation aspects of the programme. - **Done.** Meeting organised between A.Price and R.McLauchlan a success. 2. **[raw-attachment:2020-09-24-Update-Long.pptx Update on progress]: KL** \\ 3. **[raw-attachment:LhARA-PPI-Strategy-DRAFT-HH-GJ-version-05Sep20.pdf Towards a PPI strategy for LhARA]: GJ, HH** \\ - Main stem of strategy is to raise awareness with public and with patients. Then develop the engagement as the programme progresses. - Hard to see anything which would not benefit patients and also the health services. Patient input is vital all at all stages in the development of the programme. - Management of PPI will take time. Perhaps means that we need to include some resource. Marsden PPI outreach. - HH sits on various PPI advisory groups and can make links top various institutes. - Focus on engagement rather than involvement. - StG: - Agrees re effort involved in getting broad activity. Link to the Royal Marsden will be important. - KK: - BRC links important. - SG expressed it grateful recognition of the efforts of GJ and HH and the PPI representatives in drafting the two Lay Summaries so far. Both are/will be published. 4. **Towards a clinician-engagement strategy for LhARA: StG** \\ - Neil Burnett and Adrian Crellin from Brm meeting might be pursuared to promote activity. Elizabeth Schuster, Rostoc is a researcher into the impact of microbeams. - There is a need to reach out to research-active clinicians. Probably should build up a target list in preparation for a webinar. A process such as that adopted by TP for the endstation/diagnostics development would be appropriate. - KK: - Noted the perception in the community that laser-ion beams are like nuclear fusion -- always 15 years away. - Critical to develop clear statement of what what the laser-hybrid technique can do that others cant. - Meeting: - We agreed to work towards a meeting of the relevant peer groups. TKW agreed to make contact with IoP at "top level". 5. **[https://epsrc.ukri.org/funding/calls/second-call-for-transformative-healthcare-technologies-deveopment-phase/ Transformative Healthcare Technologies second call]: KL/All** \\ [raw-attachment:2020-09-24-LhARA-THT-skel-d0.2.pdf Updated outline presented at the LhARA weekly meeting 22Sep20] \\ Discussion included: - PPI: GJ/HH - Clinician engagement: StG - Plan for preparation of proposal - Scope - Work packages - Stakeholders 6. **DONMs** \\ * TBD 7. **AoB** \\ == Agenda == 1. **[wiki:Research/DesignStudy/SteeringGroup/2020-07-03 Notes of last meeting and actions arising:]** * **KL**: Set up series of meetings with leads at partner organisations to discuss preparation of R&D programme. - **Superceded.** * **KL/CB**: Consider meeting between Imperial (and other) ion-accelerator experts with the relevant experts in CLF. - **Ongoing.** * **KL/KK**: to collaborate on the development for a proposal for such a meeting on the timescale of November 2020. - **Ongoing.** * **KL**: Ensure one representative per group at the next LhARA SG meeting. - **Stands.** * **KL**: Raise NIHR engagement with K.Gleeson. - **Done.** * **KL**: Seek PPI representative for SG. - **Done.** Welcome G. Jones and H. Hall. * **KK, JPar, CW, KL**: Make relevant contact with local PPI groups as described in item 4. - * **KL&JPar**: Write to CTRAD w/s 4 chair (KK) to ask how we might work together to raise awarenents of our programme among the patient and clinician communitites. - **Done.** Letter written and sent, see under clinician engagement below. Revised action needs to be agreed. * **KK, JPar, CW, KL, SG**: Make relevant contact with local clinician groups as described in item 4. - **Ongoing.** * **KL**: Write to J.Clarke to ask for support to reach out to relevant industry. - **Stands.** * **PA**: Make contact with MTC to see how to make contact with relevant industry. **PA/KL** will cooperate in drafting a letter. - * **KL**: Review proposed w/p structure and skills matrix taking into account comments under item 4. - **Stands.&& * **KL/RMcL**: Liaise to generate small group to coordinate development of instrumentation aspects of the programme. - **Done.** Meeting organised between A.Price and R.McLauchlan a success. 2. **[raw-attachment:2020-09-24-Update-Long.pptx Update on progress]: KL** \\ 3. **[raw-attachment:LhARA-PPI-Strategy-DRAFT-HH-GJ-version-05Sep20.pdf Towards a PPI strategy for LhARA]: GJ, HH** \\ 4. **Towards a clinician-engagement strategy for LhARA: StG** \\ 5. **[https://epsrc.ukri.org/funding/calls/second-call-for-transformative-healthcare-technologies-deveopment-phase/ Transformative Healthcare Technologies second call]: KL/All** \\ [raw-attachment:2020-09-24-LhARA-THT-skel-d0.2.pdf Updated outline presented at the LhARA weekly meeting 22Sep20] \\ Discussion to include: - PPI - Clinician engagement: - Industrial engagement: - Plan for preparation of proposal - Scope - Work packages - Stakeholders - Next steps discussion 6. **DONMs** \\ * TBD 7. **AoB** \\ ----